Leslie A Jones
CIK 1205119 · Auf SEC EDGAR ansehen ↗
Erste SEC-Einreichung: 1. Oktober 2010 · Neueste: 1. Oktober 2010
Auf dieser Seite
Insider bei
Insider-Transaktionen
Preisänderung im Vergleich zum aktuellen Kurs, bereinigt um Aktiensplits und Unternehmensmaßnahmen seit der Einreichung – nicht benchmarkt, nicht annualisiert, nicht größen-gewichtet
| Date | Ticker | Code | Aktien | Kurs | Wert | Besessen danach | Δ Eigenbesitz | A/D | vs jetzt |
|---|---|---|---|---|---|---|---|---|---|
| 8. Dezember 2014 | XRAY | S | 18.000 | $55,45 | $998.100 | 94.801 Direkt | -15,96% | Veräußert | -80,3% (Preis per 2026-08-20) |
| 25. August 2014 | XRAY | S | 2.000 | $48,30 | $96.600 | 94.801 Direkt | -2,07% | Veräußert | -77,3% (Preis per 2026-08-20) |
| 19. Mai 2014 | XRAY | S | 400 | $46,49 | $18.596 | 97.492 Direkt | -0,41% | Veräußert | -76,5% (Preis per 2026-08-20) |
| 19. Mai 2014 | XRAY | S | 1.600 | $46,49 | $74.384 | 95.892 Direkt | -1,64% | Veräußert | -76,5% (Preis per 2026-08-20) |
| 8. November 2013 | XRAY | S | 2.000 | $47,68 | $95.360 | 97.892 Direkt | -2,00% | Veräußert | -77,1% (Preis per 2026-08-20) |
| 8. November 2013 | XRAY | S | 2.000 | $47,68 | $95.360 | 97.892 Direkt | -2,00% | Veräußert | -77,1% (Preis per 2026-08-20) |
| 3. Juni 2013 | XRAY | S | 2.840 | $41,76 | $118.598 | 99.892 Direkt | -2,76% | Veräußert | -73,8% (Preis per 2026-08-20) |
| 6. November 2012 | XRAY | S | 10.000 | $39,56 | $395.600 | 102.732 Direkt | -8,87% | Veräußert | -72,3% (Preis per 2026-08-20) |
| 7. August 2012 | XRAY | S | 3.900 | $38,03 | $148.317 | 112.732 Direkt | -3,34% | Veräußert | -71,2% (Preis per 2026-08-20) |
| 24. Februar 2012 | XRAY | S | 18.000 | $38,38 | $690.840 | 161.265 Direkt | -10,04% | Veräußert | -71,5% (Preis per 2026-08-20) |
| 2. August 2011 | XRAY | S | 7.740 | $37,60 | $291.024 | 161.265 Direkt | -4,58% | Veräußert | -70,9% (Preis per 2026-08-20) |
| 9. November 2010 | XRAY | S | 5.642 | $31,52 | $177.836 | 169.005 Direkt | -3,23% | Veräußert | -65,3% (Preis per 2026-08-20) |
| 11. August 2010 | XRAY | S | 1.800 | $30,78 | $55.404 | 174.647 Direkt | -1,02% | Veräußert | -64,5% (Preis per 2026-08-20) |
| 10. Mai 2010 | XRAY | S | 1.900 | $35,18 | $66.842 | 176.447 Direkt | -1,07% | Veräußert | -68,9% (Preis per 2026-08-20) |
| 5. März 2010 | XRAY | S | 2.900 | $33,88 | $98.252 | 178.347 Direkt | -1,60% | Veräußert | -67,7% (Preis per 2026-08-20) |
| 9. Februar 2009 | XRAY | S | 6.811 | $26,73 | $182.058 | 181.247 Direkt | -3,62% | Veräußert | -59,1% (Preis per 2026-08-20) |
| 9. Februar 2009 | XRAY | S | 10.900 | $26,73 | $291.357 | 188.058 Direkt | -5,48% | Veräußert | -59,1% (Preis per 2026-08-20) |
| 9. Februar 2009 | XRAY | S | 100 | $26,81 | $2.681 | 198.958 Direkt | -0,05% | Veräußert | -59,2% (Preis per 2026-08-20) |
| 9. Februar 2009 | XRAY | S | 7.000 | $26,80 | $187.600 | 199.058 Direkt | -3,40% | Veräußert | -59,2% (Preis per 2026-08-20) |
Zeige die neuesten 100 von 154 Transaktionen
K = Kauf auf offener Markt · V = Verkauf · A = Zuteilung/Auszeichnung · M = Optionsausübung · G = Geschenk · F = Steuereinbehalt
Insider-Transaktionen sind keine Empfehlung; Verkäufe werden oft aus Liquiditäts- oder steuerlichen Gründen getätigt.
Derivate-Bestände (Formular 4 Tabelle II)
Optionen, RSUs und wandelbare Wertpapiere, die in Formular 4 Tabelle II gemeldet werden.
| Date | Ticker | Wertpapier | Basiswert | Ausübungspreis | Verfall | Aktien | A/D |
|---|---|---|---|---|---|---|---|
| 20. Mai 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.739) | $52,37 | — | 1.739 | Veräußert |
| 20. Mai 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.584) | $52,37 | — | 1.584 | Veräußert |
| 10. April 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 24. März 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (264) | — | — | 264 | Erworben |
| 9. Januar 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (9) | — | — | 9 | Erworben |
| 23. Dezember 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (346) | — | — | 346 | Erworben |
| 8. Dezember 2014 | XRAY | Stock Option | Common Stock (18.000) | $28,00 | 11. Juni 2015 | 18.000 | Veräußert |
| 10. Oktober 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 23. September 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (308) | — | — | 308 | Erworben |
| 11. Juli 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 24. Juni 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (392) | — | — | 392 | Erworben |
| 25. Mai 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (909) | $46,90 | — | 909 | Veräußert |
| 21. Mai 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.390) | — | — | 1.390 | Erworben |
| 21. Mai 2014 | XRAY | Stock Option | Common Stock (6.500) | $46,77 | 21. Mai 2024 | 6.500 | Erworben |
| 11. April 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (10) | — | — | 10 | Erworben |
| 24. März 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (302) | — | — | 302 | Erworben |
| 10. Januar 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (9) | — | — | 9 | Erworben |
| 26. Dezember 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (380) | — | — | 380 | Erworben |
| 11. Oktober 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (10) | — | — | 10 | Erworben |
| 24. September 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (318) | — | — | 318 | Erworben |
| 12. Juli 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 25. Juni 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (458) | — | — | 458 | Erworben |
| 22. Mai 2013 | XRAY | Stock Option | Common Stock (6.200) | $41,47 | 22. Mai 2023 | 6.200 | Erworben |
| 22. Mai 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.567) | — | — | 1.567 | Erworben |
| 12. April 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (8) | $0,00 | — | 8 | Erworben |
| 22. März 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (341) | — | — | 341 | Erworben |
| 11. Januar 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (8) | — | — | 8 | Erworben |
| 20. Dezember 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (453) | — | — | 453 | Erworben |
| 12. Oktober 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (8) | — | — | 8 | Erworben |
| 24. September 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (407) | — | — | 407 | Erworben |
| 13. Juli 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | $37,81 | — | 6 | Erworben |
| 25. Juni 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (525) | — | — | 525 | Erworben |
| 23. Mai 2012 | XRAY | Stock Option | Common Stock (6.900) | $38,02 | 23. Mai 2022 | 6.900 | Erworben |
| 23. Mai 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.710) | $0,00 | — | 1.710 | Erworben |
| 12. Mai 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.367) | $39,26 | — | 1.367 | Veräußert |
| 13. April 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $40,13 | — | 7 | Erworben |
| 23. März 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (305) | — | — | 305 | Erworben |
| 24. Februar 2012 | XRAY | Stock Option | Common Stock (18.000) | $18,63 | 11. Juni 2012 | 18.000 | Veräußert |
| 10. Januar 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (8) | $34,99 | — | 8 | Erworben |
| 22. Dezember 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (474) | $0,00 | — | 474 | Erworben |
| 10. Oktober 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (8) | $32,43 | — | 8 | Erworben |
| 26. September 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (423) | — | — | 423 | Erworben |
| 8. Juli 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $38,08 | — | 7 | Erworben |
| 8. Juli 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (58) | $38,08 | — | 58 | Erworben |
| 27. Juni 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (466) | — | — | 466 | Erworben |
| 25. Mai 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (894) | $0,00 | — | 894 | Erworben |
| 25. Mai 2011 | XRAY | Stock Option | Common Stock (7.600) | $38,57 | 25. Mai 2021 | 7.600 | Erworben |
| 8. April 2011 | XRAY | RSU (Restricted Stock Unit) Granted | Common Stock (6) | $36,49 | — | 6 | Erworben |
| 25. März 2011 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (382) | $36,14 | — | 382 | Erworben |
| 7. Januar 2011 | XRAY | RSU (Restricted Stock Unit) Granted [F1] | Common Stock (6) | $34,54 | — | 6 | Erworben |
| 27. Dezember 2010 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (23) | $34,54 | — | 23 | Erworben |
| 7. Oktober 2010 | XRAY | RSU (Restricted Stock Unit) Granted [F1] | Common Stock (7) | $31,87 | — | 7 | Erworben |
| 29. September 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (25) | $31,87 | — | 25 | Erworben |
| 8. Juli 2010 | XRAY | Additional RSUs [F1] | Common Stock (7) | $31,03 | — | 7 | Erworben |
| 28. Juni 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (26) | $31,11 | — | 26 | Erworben |
| 6. April 2010 | XRAY | Additional RSUs [F1] | Common Stock (5) | $34,17 | — | 5 | Erworben |
| 24. März 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (23) | — | — | 23 | Erworben |
| 9. Januar 2010 | XRAY | Additional RSUs [F1] | Common Stock (4) | $35,44 | — | 4 | Erworben |
| 18. Dezember 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (23) | — | — | 23 | Erworben |
| 6. Oktober 2009 | XRAY | Phantom Stock (Deferred Compensation) | Common Stock (23) | $34,64 | — | 23 | Erworben |
| 6. Oktober 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $33,60 | — | 5 | Erworben |
| 7. Juli 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $30,93 | — | 5 | Erworben |
| 22. Juni 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (27) | $29,27 | — | 27 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.053) | $29,70 | 12. Mai 2019 | 3.053 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.054) | $29,70 | 12. Mai 2019 | 3.054 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.053) | $29,70 | 12. Mai 2019 | 3.053 | Erworben |
| 12. Mai 2009 | XRAY | Restricted Stock Unit | Common Stock (1.343) | — | — | 1.343 | Erworben |
| 8. April 2009 | XRAY | Additional RSUs [F1] | Common Stock (3) | $27,50 | — | 3 | Erworben |
| 18. März 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (32) | $24,84 | — | 32 | Erworben |
| 9. Februar 2009 | XRAY | Stock Option | Common Stock (7.000) | $8,92 | 11. Juni 2009 | 7.000 | Veräußert |
| 9. Februar 2009 | XRAY | Stock Option | Common Stock (100) | $8,92 | 11. Juni 2009 | 100 | Veräußert |
| 9. Februar 2009 | XRAY | Stock Option | Common Stock (10.900) | $8,92 | 11. Juni 2009 | 10.900 | Veräußert |
| 9. Januar 2009 | XRAY | Additional RSUs [F1] | Common Stock (3) | $26,50 | — | 3 | Erworben |
| 17. Dezember 2008 | XRAY | Director's Deferred Comp - Phantom Stock | Common Stock (27) | $26,83 | — | 27 | Erworben |
| 7. Oktober 2008 | XRAY | Additional RSUs [F1] | Common Stock (2) | — | — | 2 | Erworben |
| 6. Oktober 2008 | XRAY | Phantom Stock (3Q2008 Deferred Compensation) | Common Stock (20) | $34,94 | — | 20 | Erworben |
| 28. Juli 2008 | XRAY | Director Stock Option | Common Stock (399) | $39,39 | 28. Juli 2018 | 399 | Erworben |
| 28. Juli 2008 | XRAY | Director Stock Option | Common Stock (398) | $39,39 | 28. Juli 2018 | 398 | Erworben |
| 28. Juli 2008 | XRAY | Director Stock Option | Common Stock (399) | $39,39 | 28. Juli 2018 | 399 | Erworben |
| 28. Juli 2008 | XRAY | Director RSU July 2008 | Common Stock (174) | — | — | 174 | Erworben |
| 8. Juli 2008 | XRAY | Additional RSUs [F1] | Common Stock (2) | — | — | 2 | Erworben |
| 24. Juni 2008 | XRAY | Phantom Stock (2Q2008 Deferred Compensation) | Common Stock (19) | $38,09 | — | 19 | Erworben |
| 11. Juni 2008 | XRAY | Director Stock Option | Common Stock (1.614) | $37,69 | 11. Juni 2018 | 1.614 | Erworben |
| 11. Juni 2008 | XRAY | Director Stock Option | Common Stock (1.614) | $37,69 | 11. Juni 2018 | 1.614 | Erworben |
| 11. Juni 2008 | XRAY | Director Stock Option | Common Stock (1.614) | $37,69 | 11. Juni 2018 | 1.614 | Erworben |
| 13. Mai 2008 | XRAY | Stock Option | Common Stock (138) | $41,07 | 13. Mai 2018 | 138 | Erworben |
| 13. Mai 2008 | XRAY | Stock Option | Common Stock (138) | $41,07 | 13. Mai 2018 | 138 | Erworben |
| 13. Mai 2008 | XRAY | Stock Option | Common Stock (138) | $41,07 | 13. Mai 2018 | 138 | Erworben |
| 13. Mai 2008 | XRAY | Director RSU May 2008 | Common Stock (760) | — | — | 760 | Erworben |
| 7. April 2008 | XRAY | Additional RSUs [F1] | Common Stock (1) | — | — | 1 | Erworben |
| 27. März 2008 | XRAY | Phantom Stock (1Q2008 Deferred Compensation) | Common Stock (18) | $38,41 | — | 18 | Erworben |
| 8. Januar 2008 | XRAY | Additional RSUs [F1] | Common Stock (1) | — | — | 1 | Erworben |
| 21. Dezember 2007 | XRAY | Phantom Stock (4Q2007 Deferred Compensation) | Common Stock (308) | $44,21 | — | 308 | Erworben |
| 9. Oktober 2007 | XRAY | Additional RSUs [F1] | Common Stock (1) | — | — | 1 | Erworben |
| 26. September 2007 | XRAY | Phantom Stock (3Q2007 Deferred Compensation) | Common Stock (296) | $40,89 | — | 296 | Erworben |
| 31. Juli 2007 | XRAY | Director Stock Option | Common Stock (160) | $36,49 | 31. Juli 2017 | 160 | Erworben |
| 31. Juli 2007 | XRAY | Director Stock Option | Common Stock (161) | $36,49 | 31. Juli 2017 | 161 | Erworben |
| 31. Juli 2007 | XRAY | Director Stock Option | Common Stock (160) | $36,49 | 31. Juli 2017 | 160 | Erworben |
| 31. Juli 2007 | XRAY | Director RSU July 2007 | Common Stock (863) | — | — | 863 | Erworben |
| 29. Juni 2007 | XRAY | Phantom Stock (2Q2007 Deferred Compensation) | Common Stock (381) | $38,26 | — | 381 | Erworben |
Zeige die neuesten 100 von 124 Transaktionen
Ausübungs-/Umwandlungspreis ist leer, wenn nicht zutreffend (z. B. RSUs).